Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic

AIDS

Volumn 17, Issue 6, 2003, Pages 887-893

  Tyndall, Mark W ^a,b   Currie, Sue ^a   Spittal, Patricia ^a   Li, Kathy ^a   Wood, Evan ^a   O'Shaughnessy, Michael V ^a   Schechter, Martin T ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

Author keywords

AIDS; Cocaine; HIV; Injecting drug use

Indexed keywords

DIAMORPHINE;

ADULT; ARTICLE; CANADA; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG ABUSE PATTERN; EPIDEMIC; ETHNOLOGY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; INFECTION SENSITIVITY; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEROCONVERSION;

ADULT; BRITISH COLUMBIA; COCAINE-RELATED DISORDERS; DISEASE OUTBREAKS; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-1; HUMANS; MALE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0038708362     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200304110-00014     Document Type: Article

References (32)

1. Patrick D, Strathdee S, Archibald C, Ofner M, Craib KJ, Cornelisse PG, et al. Determinants of HIV seroconversion in injection drug users during a time of rising prevalence in Vancouver. Int J STD AIDS 1997, 8:437-445.
2. Strathdee SA, Patrick DM, Currie SL, Cornelisse PG, Rekart ML, Montaner JS, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS 1997, 11:F59-F65.
3. Tyndall MW, Craib KJ, Currie S, Li K, O'Shaughnessy MV, Schechter MT. Impact of HIV infection on mortality in a cohort of injection drug users. J Acquir Immune Defic Syndr 2001, 28:351-357.
4. Schechter MT, Strathdee SA, Cornelisse PG, Currie S, Patrick DM, Rekart ML, et al. Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak. AIDS 1999, 13:F45-F51.
5. Moss AR. Epidemiology and the politics of needle exchange [see comments]. Am J Public Health 2000, 90:1385-1387.
6. Vlahov D, Junge B, Brookmeyer R, Cohn S, Riley E, Armenian H, et al. Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 16:400-406.
7. Hurley SF, Jolley DJ, Kaldor JM. Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet 1997, 349:1797-1800.
8. Ward J, Hall W, Mattick RP. Role of maintenance treatment in opioid dependence. Lancet 1999, 353:221-226.
9. Drucker E, Lurie P, Wodak A, Alcabes P. Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV. AIDS 1998, 12(Suppl A):S217-S230.
10. Kral AH, Bluthenthal RN, Booth RE, Watters JK. HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities. Am J Public Health 1998, 88:108-13.
11. Des Jarlais DC, Marmor M, Friedmann P, Titus S, Aviles E, Deren S, et al. HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic. Am J Public Health 2000, 90:352-359.
12. van Ameijden EJ, van den Hoek AR, Coutinho RA. Injecting risk behavior among drug users in Amsterdam, 1986 to 1992, and its relationship to AIDS prevention programs. Am J Public Health 1994, 84:275-281.
13. Des Jarlais DC, Marmor M, Paone D, Titus S, Shi Q, Perlis T, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet 1996, 348:987-991.
14. Zaric GS, Barnett PG, Brandeau ML. HIV transmission and the cost-effectiveness of methadone maintenance. Am J Public Health 2000, 90:1100-1111.
15. Gibson DR, Flynn NM, Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS 2001, 15:1329-1341.
16. Guadagnino V, Zimatore G, Izzi A, Caroleo B, Rocca A, Montesano F, et al. Relevance of intravenous cocaine use in relation to prevalence of HIV, hepatitis B and C virus markers among intravenous drug abusers in southern Italy. J Clin Lab Immunol 1995, 47:1-9.
17. Chaisson RE, Bacchetti P, Osmond D, Brodie B, Sande MA, Moss AR. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA 1989, 261:561-565.
18. Monterroso ER, Hamburger ME, Vlahov D, Des Jarlais DC, Ouellet LJ, Altice FL, et al. Prevention of HIV infection in street-recruited injection drug users. The Collaborative Injection Drug User Study (CIDUS). J Acquir Immune Defic Syndr 2000, 25:63-70.
19. Edlin BR, Irwin KL, Faruque S, McCoy CB, Word C, Serrano Y, et al. Intersecting epidemics-crack cocaine use and HIV infection among inner-city young adults. Multicenter Crack Cocaine and HIV Infection Study Team [see comments]. N Engl J Med 1994, 331:1422-1427.
20. Magura S, Kang SY, Nwakeze PC, Demsky S. Temporal patterns of heroin and cocaine use among methadone patients. Substance Use Misuse 1998, 33:2441-2467.
21. Hyman SE. A 28-year-old man addicted to cocaine. JAMA 2001, 286:2586-2594.
22. Remis RS, Bruneau J, Hankins CA. Enough sterile syringes to prevent HIV transmission among injection drug users in Montreal? J Acquir Immune Defic Syndr Hum Retrovirol 1998, 18(Suppl 1):S57-S59.
23. Wood E, Tyndall MW, Li K, Spittal PM, Kerr T, Hogg RS, et al. Continuing unsafe injection practices in a cohort of injection drug users: could safer injecting rooms help? Can Med Ass J 2001, 165:405-410.
24. Wohl AR, Johnson D, Jordan W, Lu S, Beall G, Currier J, et al. High-risk behaviors during incarceration in African-American men treated for HIV at three Los Angeles public medical centers. J Acquir Immune Defic Syndr 2000, 24:386-392.
25. Rich JD, Dickinson BP, Macalino G, Flanigan TP, Towe CW, Spaulding A, et al. Prevalence and incidence of HIV among incarcerated and reincarcerated women in Rhode Island. J Acquir Immune Defic Syndr 1999, 22:161-166.
26. Booth RE, Watters JK, Chitwood DD. HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack. Am J Public Health 1993, 83:1144-1148.
27. Tyndall MW, Patrick D, Spittal P, Li K, O'Shaughnessy MV, Schechter MT. Risky sexual behaviours among injection drugs users with high HIV prevalence: implications for STD control. Sex Transm Infect 2002, 78(Suppl 1): 170-175.
28. Hartel DM, Schoenbaum EE, Selwyn PA, Kline J, Davenny K, Klein RS, et al. Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use. Am J Public Health 1995, 85:83-88.
29. Latkin CA, Vlahov D, Anthony JC. Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction 1993, 88:517-526.
30. De Irala J, Bigelow C, McCusker J, Hindin R, Zheng L. Reliability of self-reported human immunodeficiency virus risk behaviors in a residential drug treatment population. Am J Epidemiol 1996, 143:725-732.
31. Surratt HL. Indigence, marginalization and HIV infection among Brazilian cocaine users. Drug Alcohol Depend 2000. 58:267-274.
32. Frank B, Galea J. Cocaine trends and other drug trends in New York City, 1986-1994. J Addict Dis 1996, 15:1-12.